Kim Janda

Insider Reports History

Location
San Diego, CA
Signature
/s/ Henry Ji, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim Janda:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sorrento Therapeutics, Inc. Director Common Stock 3,000 $2,408 $0.8027 27 Dec 2021 Direct
Sorrento Therapeutics, Inc. Director Non-qualified stock option 0 27 Dec 2021 Direct

Insider Reports Filed by Kim Janda

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123007395-janda-kim-2021-12-31 Sorrento Therapeutics, Inc. 31 Dec 2021 1 -$31,273 5 Director 06 Feb 2023, 20:10
/report/000120919121071311-janda-kim-2021-12-27 Sorrento Therapeutics, Inc. 27 Dec 2021 3 -$5,640 4 Director 27 Dec 2021, 18:34
/report/000120919121057957-janda-kim-2021-09-27 Sorrento Therapeutics, Inc. 27 Sep 2021 5 -$250,456 4 Director 28 Sep 2021, 17:37
/report/000120919121055954-janda-kim-2021-09-13 Sorrento Therapeutics, Inc. 13 Sep 2021 3 -$36,285 4 Director 14 Sep 2021, 17:00
/report/000120919121053982-janda-kim-2021-08-30 Sorrento Therapeutics, Inc. 30 Aug 2021 1 $0 4 Director 30 Aug 2021, 20:13